FDA Approved: ANGELIQ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Angeliq (drospi renone and estradiol) from Bayer, updating labeling for postmenopausal indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Postmenopausal Osteoporosis

Drugs mentioned

• ANGELIQ (DROSPIRENONE AND ESTRADIOL)

Snippet

SUPPL AP for ANGELIQ (DROSPIRENONE AND ESTRADIOL)